DM

Showing posts with label Enzymes. Show all posts
Showing posts with label Enzymes. Show all posts

Friday, July 19, 2013

Are Enzymes The Best Treatment For Pancreatic Cancer?

Pancreatic cancer is regarded as the deadliest and hard to deal with cancer out there. To address the fast formation of tumors in the body, experts and scientists are busy finding ways to stop the development of cancer and gradually eliminate it from forming. Also, they are busy studying alternative treatments for cancer patients, and one of these alternative medicine for cancer is the use of enzymes. Enzymes are believed to battle against the growth and development of pancreatic cancer, which is notorious in fighting off customary anti-cancer drugs.

Just What Are Enzymes?

Fundamental biochemical elements which take on a vital role in the majority of capabilities in every organ system within the body are known as enzymes. Enzymes are catalysts in a way. They are components that improve the overall pace and strengthen biochemical reactions that handle the basic progress of lifecycles in each productive organism. The entire body cannot do without the aid of enzymes because each and every enzyme active in our body has a individual purpose to fulfill.

Our gastrointestinal tract has digestive enzymes that take apart food on a regular basis. This procedure makes it possible for nutritional requirements to be soaked up and taken in by the bloodstream. Digestive enzymes located in the intestinal juices, pancreatic juices and stomach juices are called proteases or proteolytic enzymes. These proteases facilitate digesting proteins. In addition, proteases are also found to be chockfull of analgesic, anti-inflammatory, to immune-regulating qualities.

Enzymes as Treatment

Traditional medicine have long benefited from the advantages of enzymes. Plant extracts with exceptional numbers of proteolytic enzymes are widely-used in medicines to take care of different diseases even today. In addition to proteolytic enzymes located in plants like bromelain and papain, proteolytic pancreatic enzymes like chymotrypsin and pepsin are also highly valued in enzyme therapy.

Ongoing studies have shown that proteases or proteolytic enzymes can bring in excellent benefits when it comes to cancer therapy by expanding the life of a patient affected by the ailment. It cuts down on symptoms of the illness and the disadvantageous negative effects caused by basic cancer remedies like chemotherapy and radiotherapy.

A rudimentary enzyme therapy is a routine that features four parts. Patients that have chosen alternative treatments for pancreatic cancer like enzyme therapy are recommended to take in sizeable amounts of enzymes and are also required to manage an organic diet without any processed food. Also, they are requested to take in considerable doses of mineral and vitamin supplements. Everyday detoxification methods like coffee enemas are also carried out to persistently flush out the consequential build-up of waste products located in the liver.

Alternative treatments for pancreatic cancer were meticulously reviewed and evaluated and function as a substitute for basic cancer healing. Treatments like chemotherapy have adverse effects on a cancer patient, thus scientists paid attention to more plant-based, holistic, "gentler" alternatives for treating the Big C. If you need more info with regards to alternative treatments, you can confer with health clinics concentrating on these types of treatments. You never know, alternative treatments for cancer patients could be that regimen that will at last cleanse your system and provide you with a new lease in life.


View the original article here

Friday, July 12, 2013

Targeting Antioxidant Enzymes With Novel Therapeutics May Selectively Kill Off Metastasizing Cancer Cells

Main Category: Cancer / Oncology
Article Date: 25 Jun 2013 - 0:00 PDT Current ratings for:
Targeting Antioxidant Enzymes With Novel Therapeutics May Selectively Kill Off Metastasizing Cancer Cells
not yet ratednot yet rated
A new study by a team of researchers from the University of Notre Dame provides an important new insight into how cancer cells are able to avoid the cell death process. The findings may suggest a chemotherapeutic approach to prevent the spread of cancers.

Metastasis, the spread of cancer from one organ to other parts of the body, relies on cancer cells ability to evade a cell death process called anoikis, according to Zachary T. Schafer, Coleman Assistant Professor of Cancer Biology at Notre Dame. Metalizing cancer cells are able to survive anoikis, which normally results from detachment from the extracellular matrix. However, Schafer notes that the molecular mechanisms cancer cells detached from the extracellular matrix use to survive has not been well understood.

"This paper reveals that cancer cells that are detached from their normal environment, as they would be during metastasis, relay on the activity of antioxidant enzymes to facilitate their survival," Schafer said. "This class of enzymes is critical for neutralizing oxidative stress and function much like the compounds that are present in a variety of foods."

The paper describes a prominent role for antioxidant enzymes in facilitating the survival of breast cancer cells after detachment from the extracellular matrix. Conversely, the researchers report, silencing antioxidant enzyme expression reduced tumor formation.

"The results in this paper suggest that targeting antioxidant enzymes with novel therapeutics may selectively kill off metastasizing cancer cells," Schafer said.

Article adapted by Medical News Today from original press release. Click 'references' tab above for source.
Visit our cancer / oncology section for the latest news on this subject. The paper appears in the journal Cancer Research, which is the most frequently cited cancer journal in the world.

The researchers collaborated with Matthew Leevy in Notre Dame's in vivo imaging facility.

Other authors of the paper include doctoral student Calli Davison, rising junior Sienna Durbin, 2011 alum Matthew Thau, graduate student Victoria Zellmer, and Sarah Chapman, Justin Diner and Connor Wathen from the Notre Dame Integrated Imaging Facility.

University of Notre Dame

Please use one of the following formats to cite this article in your essay, paper or report:

MLA

University of Notre Dame. "Targeting Antioxidant Enzymes With Novel Therapeutics May Selectively Kill Off Metastasizing Cancer Cells." Medical News Today. MediLexicon, Intl., 25 Jun. 2013. Web.
25 Jun. 2013. APA

Please note: If no author information is provided, the source is cited instead.


'Targeting Antioxidant Enzymes With Novel Therapeutics May Selectively Kill Off Metastasizing Cancer Cells'

Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.

If you write about specific medications or operations, please do not name health care professionals by name.

All opinions are moderated before being included (to stop spam)

Contact Our News Editors

For any corrections of factual information, or to contact the editors please use our feedback form.

Please send any medical news or health news press releases to:

Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.



View the original article here